Carreño et al. explored the metabolic pathways of fructose in prostate cancer cells, noting that despite low expression of Glut-1, these cells efficiently utilize fructose to support proliferation and growth, with fructose metabolism potentially promoting cancer cell proliferation through de novo lipogenesis pathways 99. This evidence concerns the gene SLC2A1 and cancer.